Saturday, May 8th, 2010 - Medpace Reference Labs
Medpace Reference Labs (MRL) Central Labs in China and India Achieve CAP Accreditation, NGSP Level 1 and CDC Lipid Standardization Part III Standardization, Completing the Company's Ability to Deliver Global, Identical, Highly Standardized Laboratory Services in Its Own Facilities

CINCINNATI, OH--(Marketwire) - Medpace Reference Laboratories LLC (MRL), a Medpace company, announced today that its new laboratories in Beijing, China and Mumbai, India have achieved accreditation by the College of American Pathologists (CAP), NGSP Level 1 and CDC Lipid Standardization (LSP) Part III. They complement laboratories in Leuven, Belgium and Cincinnati, USA with the same accreditations providing MRL the ability to deliver consistent, identical and highly standardized laboratory analysis to support clinical trials throughout the world. Accreditation by these internationally recognized programs reflect the high standards to which MRL is committed to achieve and maintain in order to best serve the pharmaceutical drug development process by seamlessly analyzing and incorporating safety and efficacy laboratory data across the globe.

The China and India facilities, like those in the USA and Europe, are wholly owned and operated in owned MRL state-of-the-art facilities which have been equipped with identical instrumentation, use the same reagent systems, calibration, QA and SOPs. All MRL laboratories are directly supervised by onsite, full-time doctoral level laboratory professionals including MDs and PhDs with training and board certification in Pathology/Laboratory Medicine.

"We believe that building a global network of identical and now fully accredited laboratories from scratch in only four years reflects the enormous experience, hard work and commitment to global excellence of our core team of laboratory professionals in the USA and Europe many of whom have worked together in clinical trials for nearly 20 years" said Evan Stein, MD Ph.D. FCAP, FRCP (C), Chief Scientific Officer and Global Lab Director for MRL. "We are most appreciative of our pharmaceutical clients who made us the fastest start up of any central laboratory and not only sustained but encouraged our rapid growth into these new regions."

Contact Profile

Medpace Reference Labs

MRL is a full-service central laboratory with locations in the USA, Belgium, China, and India. MRL uses state-of-the-art instrumentation and methods, which are identical at all MRL global sites. MRL provides production and shipping of specimen collection kits; formally correlated testing menus; customized reporting and delivery options to accommodate international requirements; long-term archival specimen storage; and appropriate quality assurance and is CAP accredited and has NGSP Level 1 and CDC Lipid Standardization Part III standardization.
Mary Kuramoto
P: +1 513-579-9911 X 2523


Medpace is a leading global full-service clinical research organization providing Phase I-IV core development services for drug, biologic, and device programs. With medical and regulatory expertise in multiple therapeutic specialties, Medpace has assembled the industry's most experienced and therapeutically focused teams to execute at every level of the company's operations, providing complete and seamless drug development services. In June 2009, Medpace was rated as the best CRO by U.S. Investigators in the 2009 CenterWatch Site Survey.

Medpace creates strategic partnerships with pharmaceutical and biotechnology companies to provide the most efficient and cost-effective path to drug development -- from program planning and execution to product approval.

With 900+ employees and clinical trial experience in over 40 countries, Medpace has the global reach and capability to conduct studies and navigate regulatory requirements worldwide. In addition to Phase II-IV development services, Medpace provides Phase I / IIA clinical services from Medpace Clinical Pharmacology, central laboratory and therapeutically specialized testing from Medpace Reference Laboratories, complete bioanalytical services in all stages of drug development from Medpace Bioanalytical Laboratories, and central image management and reading from Imagepace.

For more information visit the Medpace website at:


Medpace Reference Labs (MRL) Central Labs,China, India, CAP Accreditation, NGSP Level 1, CDC Lipid Standardization, Part III Standardization



More Formats